Publications by authors named "Penny Heaton"

Claim this Profile
S
Successes and Opportunities during the Pandemic: Reflections and Revelations from a Vaccine Development Perspective.
Penny M Heaton, Kavitha Palaniappan, Anne-Claire Stona, Silke Vogel, John C W Lim

Clin Pharmacol Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Study of Rivaroxaban vs Placebo on Disease Progression and Symptoms Resolution in High-Risk Adults With Mild Coronavirus Disease 2019.
Jintanat Ananworanich, Robin Mogg, Michael W Dunne, Mohamed Bassyouni, Consuela Vera David, Penny Heaton

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases.
Felix Calderón, Lluis Ballell, David Barros, Graeme Bilbe, Nicholas Cammack, Penny M Heaton

Nat Rev Drug Discov· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herd Immunity: The Journey Is as Important as the Destination.
Penny M Heaton

J Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities.
Jintanat Ananworanich, Penny M Heaton

Vaccines (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges of Developing Novel Vaccines With Particular Global Health Importance.
Penny M Heaton

Front Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Covid-19 Vaccine-Development Multiverse. Reply.
Penny M Heaton

N Engl J Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Covid-19 Vaccine-Development Multiverse.
Penny M Heaton

N Engl J Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials in the pandemic age: What is fit for purpose?
Dan Hartman, Penny Heaton, Nick Cammack, Ian Hudson, Shawn Dolley

Gates Open Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Patient to Molecule: In Pursuit of Universal Treatments for TB.
Penny M Heaton, Jeffrey S Barrett

Clin Transl Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why Child Health and Mortality Prevention Surveillance?
Scott F Dowell, Anita Zaidi, Penny Heaton

Clin Infect Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data: An Unrealized Opportunity in Global Health?
Jeffrey S Barrett, Penny M Heaton

Clin Pharmacol Ther· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study.
Dimitrios Gouglas, Tung Thanh Le, Klara Henderson, Aristidis Kaloudis, Trygve Danielsen, Penny M Heaton

Lancet Glob Health· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparing Physician-Scientists for an Evolving Research Ecosystem.
Matthew E Hirschtritt, Penny M Heaton, Thomas R Insel

JAMA· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precisely Tracking Childhood Death.
Tamer H Farag, Jeffrey P Koplan, Robert F Breiman, Shabir A Madhi, Penny M Heaton

Am J Trop Med Hyg· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries.
Christopher L Karp, Deborah Lans, José Esparza, Eleanore B Edson, Katey E Owen, Penny M Heaton

Vaccine· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).
Penelope H Dennehy, Timo Vesikari, David O Matson, Robbin F Itzler, Michael J Dallas, Penny M Heaton

Hum Vaccin· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilization.
Celia D C Christie, Newton D Duncan, Kirk A Thame, Matthew T Onorato, Hyacinth D Smith, Penny M Heaton

Pediatrics· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine.
Haifeng Song, Vaughan Wittman, Anthony Byers, Tenekua Tapia, Bin Zhou, Penny Heaton

Vaccine· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5).
Robbin Itzler, Gary Koch, David O Matson, Leif Gothefors, Pierre Van Damme, Penny M Heaton

BMC Pediatr· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age dependence of the risk of intussusception following [corrected] rhesus-human reassortant rotavirus tetravalent vaccine: is it beyond doubt?
Jie Chen, Joseph F Heyse, Penny Heaton, Barbara J Kuter

Am J Epidemiol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.
Matthew R Murawski, Lori W McGinnes, Robert W Finberg, Evelyn A Kurt-Jones, Michael J Massare, Penny M Heaton

J Virol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe.
Timo Vesikari, Robbin Itzler, Aino Karvonen, Tiina Korhonen, Pierre Van Damme, Penny M Heaton

Vaccine· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets.
Ted M Ross, Kutub Mahmood, Corey J Crevar, Kirsten Schneider-Ohrum, Penny M Heaton

PLoS One· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
Max Ciarlet, Su He, Sherry Lai, Maria Petrecz, Guojun Yuan, Penny M Heaton

Pediatr Infect Dis J· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis